This page collects the key figures and concepts from this lesson. Use it as a study reference; HSCI 230, 341, and 410 will assume familiarity with this material.

Key figures introduced in this lesson

A consolidated course glossary will be published on the HSCI 130 index page.

Introduction and Overview

The shift from miasma theory to germ theory in the second half of the 19th century is the single largest theoretical paradigm shift in the history of medicine. Almost everything you know about modern infection control, food safety, vaccination, surgery, and antibiotic therapy descends from this revolution. The revolution had a small number of central figures — Pasteur, Koch, Lister, and (often forgotten in the standard story) Semmelweis. They were not collaborators; they worked in different countries, with different methods, on different problems. But within roughly thirty years, between approximately 1860 and 1890, the collective work of these four men and their networks displaced a 2,000-year-old theoretical framework and replaced it with one we still use, in elaborated form, in 2026.

Louis Pasteur: from fermentation to vaccination

Louis Pasteur (1822–1895) was trained as a chemist, not a physician, which is partly why he was able to see what physicians could not. Pasteur's first major scientific contributions were on molecular asymmetry in crystals (1840s), and on the chemistry of fermentation (1850s). His work on fermentation led him to the observation — initially focused on wine and beer spoilage — that specific microorganisms produced specific fermentation outcomes. By the 1860s, Pasteur had concluded that microorganisms were not spontaneously generated from organic matter (as had been widely believed) but were transmitted from one place to another. His famous swan-necked flask experiments (1864) showed that broth left open to air via a curved neck — which trapped airborne particles — remained sterile, while broth exposed directly to air spoiled. The work definitively disproved spontaneous generation and set the stage for germ theory.

Pasteur extended the work to disease. He showed that pébrine, a silkworm disease devastating the French silk industry, was caused by a specific microorganism, and developed methods to control it. He demonstrated similar microbial causes for chicken cholera and anthrax. In 1881, he conducted a famous public demonstration at Pouilly-le-Fort, vaccinating sheep against anthrax with attenuated bacteria he had cultured; the vaccinated sheep survived a subsequent live anthrax challenge while unvaccinated controls died. The demonstration was a triumph — observed by international press and dignitaries — and established vaccination as a method that could be scientifically developed and tested, not just empirically applied as Jenner had done.

Pasteur's most famous single moment was the 1885 rabies vaccination of nine-year-old Joseph Meister, who had been savagely bitten by a rabid dog. The vaccine — which Pasteur had developed in animals but never tested in humans — was administered in increasingly potent doses over 14 days. Meister survived. The story electrified the public, and Pasteur's reputation was sealed. The Pasteur Institute was founded in 1888 (still operating in Paris and at sites worldwide), and Pasteur died in 1895 having transformed an entire field. The process by which heat treatment kills harmful microorganisms in milk and other foods — pasteurization — bears his name. Modern food safety is essentially impossible without his contributions.

Robert Koch and Koch's postulates

Robert Koch (1843–1910) was a German country doctor who, in his spare time, conducted laboratory work in his consulting room that would change medicine. Koch's first major paper (1876) identified Bacillus anthracis as the cause of anthrax in cattle and humans, providing the first definitive demonstration that a specific bacterium caused a specific disease. He went on to identify the bacterial causes of tuberculosis (Mycobacterium tuberculosis, 1882) and cholera (Vibrio cholerae, 1884). His tuberculosis paper, presented to the Berlin Physiological Society on 24 March 1882, is one of the most consequential single scientific communications in history; TB at the time was killing roughly one in seven Europeans, and identifying its cause was a precondition for everything that followed.

Beyond specific identifications, Koch contributed methodological tools that the entire field of microbiology has used ever since. He developed solid culture media — initially using gelatin and potato slices, eventually agar (suggested by Fanny Hesse, the wife of one of Koch's collaborators) — that allowed pure culture of single bacterial species. He pioneered photomicroscopy of stained bacteria, making microbial identification reproducible and shareable. And he formulated Koch's postulates — four criteria that a microorganism must meet to be considered the cause of a specific disease: (1) the organism must be present in all cases of the disease; (2) it must be isolable in pure culture from a diseased host; (3) introducing the cultured organism into a healthy host must produce the disease; (4) the organism must be re-isolable from the newly infected host.

The postulates have been refined and extended (asymptomatic carriers, viruses that can't be cultured easily, opportunistic infections, and prions all created challenges for Koch's original framework) but their basic structure — a disciplined evidentiary chain linking a candidate cause to a specific disease — has shaped all subsequent causal inference in microbiology. Koch was awarded the Nobel Prize in Physiology or Medicine in 1905 for his work on tuberculosis.

Joseph Lister and antiseptic surgery

Joseph Lister (1827–1912) was a British surgeon working in Glasgow and later London who read Pasteur's papers on fermentation in the 1860s and made an inferential leap that transformed surgery. If microorganisms caused fermentation in liquids, Lister reasoned, perhaps they also caused the infections that killed roughly 40-50% of post-surgical patients in mid-19th-century hospitals. Lister hypothesized that preventing microorganisms from entering surgical wounds would prevent post-surgical infection. He experimented with carbolic acid (phenol) — known to control sewage odors and assumed to act on the relevant 'germs' — and developed a protocol involving carbolic acid spraying of the operative field, soaking of dressings, and antiseptic preparation of instruments and hands.

The results, published in The Lancet in 1867, were dramatic. Post-surgical mortality in Lister's wards dropped substantially — by perhaps half. The technique spread, slowly at first (British surgeons were sometimes hostile to innovation from a Scottish provincial surgeon) and then rapidly. Antiseptic surgery (preventing infection by killing microorganisms) was later refined into aseptic surgery (preventing infection by maintaining sterile environments and instruments), which is the modern operating-theatre approach. The carbolic spray itself is no longer used — it was harsh on the patients and harder on the surgical team — but the underlying principle is the bedrock of all modern surgical practice.

Lister's contribution illustrates a pattern that recurs in public health history. The basic science (Pasteur's germ theory) was developed in one country and one discipline; the practical application (Lister's antisepsis) was developed in another country and another discipline; and the global adoption took decades of advocacy, demonstration, and the death of older surgeons who refused to change their practice. The mechanism by which scientific findings translate into clinical and public health practice is rarely fast and is always partly social and political.

Ignaz Semmelweis: the tragedy of being right too early

Ignaz Semmelweis (1818–1865) was a Hungarian obstetrician working at Vienna General Hospital in the 1840s, two decades before Pasteur's work and at a time when germ theory had not been articulated. He noticed something his colleagues had been observing without explanation: the maternal mortality rate from puerperal fever (childbed fever) was approximately 18% in the wards staffed by physicians, but only 2% in the wards staffed by midwives. The disparity was so large that pregnant women in Vienna sometimes begged to be admitted to the midwife wards.

Semmelweis investigated. The difference between the two wards was that physicians spent their mornings performing autopsies, including autopsies on women who had died of puerperal fever, and then delivered babies — sometimes within minutes — without washing their hands. Midwives did not perform autopsies. Semmelweis hypothesized that 'cadaverous particles' transferred from autopsies to mothers during delivery caused the fevers. In May 1847 he instituted a strict protocol requiring physicians to wash their hands with chlorinated lime water between autopsies and deliveries. Maternal mortality on the physician wards dropped from 18% to below 2%. He had matched the midwife wards. He had saved thousands of lives.

The medical establishment rejected his findings. Semmelweis was dismissed from Vienna General. His published work was poorly received. The implication — that respectable physicians were killing patients through their own carelessness — was unbearable to a profession that defined itself by competence and propriety. Semmelweis grew progressively more bitter, then erratic, then mentally ill. He was committed to an asylum in 1865 and died there at age 47, beaten by guards. He was unrecognized at his death; his findings were vindicated only after germ theory provided a theoretical framework that explained why his protocol worked.

The Semmelweis story is taught not as a triumphant medical-history vignette but as a parable about resistance to evidence in medicine. Semmelweis had the right answer. His evidence was strong. He was nonetheless ignored, mocked, and ostracized — partly because he lacked the social skills to overcome professional resistance and partly because his findings indicted his colleagues. The lesson is uncomfortable: being right is necessary but not sufficient, and even strong evidence can fail to displace strong professional interests. The pattern recurs across the history of public health, often with similar costs.

Introduction and Overview

Before any vaccine, before any antibiotic, sanitation infrastructure did more to reduce infectious disease mortality than any clinical intervention in human history. The European and North American 19th-century mortality decline — especially among children — is in large part a sanitary-revolution story. It happened largely under wrong theoretical assumptions (miasma theory rather than germ theory), motivated by social-reform politics as much as by science, and it produced effects that no amount of clinical medicine could match. Understanding the sanitary revolution forces a humbling realization: most of what made industrialized populations healthy was not delivered by clinicians or hospitals. It was delivered by engineers, public works departments, and food regulators, operating on the basis of theories that turned out to be wrong but policies that happened to work.

Sewers and the urban transformation

Between roughly 1850 and 1920, every industrialized city built underground sewer networks, central water treatment plants, and municipal garbage collection. The transformation was driven by a combination of recurring epidemics (especially cholera and typhoid), Chadwick-style sanitary reformism, and the political demands of newly enfranchised working-class populations. The engineering was extraordinary. London's modern sewer system, designed by Joseph Bazalgette after the 'Great Stink' of 1858 — when raw sewage in the Thames produced a smell so overwhelming that Parliament was nearly forced to relocate — incorporated approximately 1,800 km of street sewers and 132 km of intercepting sewers carrying waste away from the city center. Construction was completed by 1875. The system, with substantial extension and modification, is still in use in 2026.

The public health impact was dramatic. London's cholera mortality, which had been measured in the tens of thousands during outbreaks in 1832, 1848-49, and 1853-54, dropped sharply after the sewer system was completed. Typhoid mortality fell similarly. Infant mortality from diarrheal disease, which had been the leading cause of child death in industrialized cities, declined steadily through the late 19th century. The Toronto sewer expansions of the 1880s and Montreal's water filtration installations of the early 1900s correspond closely to local declines in typhoid and infant diarrheal mortality, with similar patterns observable in essentially every industrializing city.

Modern public health rarely celebrates this engineering revolution the way it celebrates vaccines and antibiotics. There is no Pasteur or Koch of sewerage; Bazalgette is barely known outside the UK. The reason is partly cultural — sanitation infrastructure is invisible when it works — and partly institutional — sewers and water treatment are not owned by health agencies but by public works departments, which makes them disappear from health narratives. The result is that public health students often underestimate how much of population health is delivered by infrastructure rather than by clinical intervention. We will return to this in later modules: housing, transit, food systems, and the built environment are all 'sanitary revolution' descendants in this sense.

Pasteurization of milk and food safety as public health

The other arm of the sanitary revolution was food safety. Pasteurization of milk — heat treatment that kills tuberculosis bacilli, Salmonella, Listeria, E. coli, and many other pathogens without rendering the milk unpalatable — was championed by figures like Nathan Straus in New York in the 1890s. Straus, a Macy's department-store owner with no formal public-health credentials, was so convinced of the importance of pasteurized milk that he funded free pasteurized-milk distribution to poor children in New York from 1893. Infant mortality in the areas served dropped dramatically. The Straus depots were a private demonstration that pasteurized milk could save children's lives, and they accelerated the political case for mandatory pasteurization.

Mandatory milk pasteurization spread through the early 20th century. Chicago required it from 1908. New York followed in 1912. Most Canadian provinces made pasteurization mandatory by the 1930s. The impact on bovine tuberculosis transmission to children alone was enormous; childhood TB rates dropped by roughly 90% in jurisdictions that mandated pasteurization. Salmonella and Listeria outbreaks from unpasteurized milk, occasionally still seen in raw-milk advocacy communities, are now treated as preventable failures of public health rather than as expected events.

The institutional infrastructure for food safety dates to the same era. The US Food and Drug Administration traces to the 1906 Pure Food and Drug Act, prompted in part by Upton Sinclair's The Jungle (1906), which exposed conditions in the Chicago meatpacking industry. Health Canada's food safety predecessor agencies emerged in the same period. Modern food safety — HACCP (Hazard Analysis and Critical Control Points) frameworks, recall systems, foodborne disease surveillance — is built on the 19th-century pasteurization foundation. It is often treated as a separate discipline from 'public health proper' but its conceptual genealogy is squarely public health.

The McKeown thesis and the role of clinical medicine

How much of the 19th- and early-20th-century mortality decline should be attributed to sanitation vs. nutrition vs. clinical medicine? This is one of the most contested questions in public health history, and the canonical position is associated with British physician and historian Thomas McKeown (1912–1988).

McKeown's argument, developed across a series of papers and books in the 1960s and 1970s (most famously The Role of Medicine: Dream, Mirage, or Nemesis?, 1976), was that the dramatic decline in mortality from infectious diseases in industrialized countries was caused primarily by improved nutrition and living conditions, not by clinical medicine. McKeown examined the timeline of mortality decline for specific diseases — tuberculosis, measles, whooping cough, diphtheria, scarlet fever — and noted that mortality often fell substantially before the specific clinical intervention (vaccine, antibiotic, specific therapy) was introduced. Therefore, McKeown argued, the intervention couldn't have caused the mortality decline; something else had.

The McKeown thesis was hugely influential. It seemed to confirm what radical and structural critics of modern medicine had long argued: that biomedical intervention had received far more credit than it deserved for population health improvements, and that broader determinants — wages, housing, nutrition, working hours — were doing most of the work. The thesis has aged less well in its strong form. Subsequent historical and epidemiological work — particularly by Szreter (1988) — has shown that McKeown underestimated the contribution of sanitation specifically, and that the mortality decline pattern is better explained by public health intervention (especially sanitation, vaccination, and selective clinical care) than by nutrition alone.

The contemporary consensus is that mortality decline was driven by a combination of factors — sanitation, nutrition, vaccination, antibiotics, broader living-condition improvements, and selective clinical interventions — with the mix varying by disease and by period. Clinical medicine's contribution is real but smaller than its share of health expenditure. Sanitation's contribution is large and underrecognized. Nutrition's contribution is substantial. The lesson is general: complex historical changes have multiple causes, and assigning credit to one is almost always misleading.

Sanitation, then and now

The sanitary revolution is sometimes treated as a 19th-century story complete in itself. It is not. In 2026, roughly 2 billion people globally do not have access to safely managed drinking water; roughly 3.6 billion lack access to safely managed sanitation. The WHO/UNICEF Joint Monitoring Programme (2023) estimates that approximately 1.4 million deaths per year are attributable to inadequate water, sanitation, and hygiene. Diarrheal disease remains a leading cause of death in children under five in low-income countries. The sanitary revolution that transformed European and North American cities between 1850 and 1920 is, in much of the world, incomplete.

Even in Canada, sanitation gaps exist. The First Nations long-term drinking water advisories issue — at one point in 2015 affecting more than 100 First Nations communities, with some advisories in effect for over 20 years — is a sanitary-revolution issue. The fact that Indigenous communities in one of the wealthiest countries on earth have repeatedly lacked reliable safe drinking water is a national disgrace and a measurable contributor to health disparities. The Trudeau government's 2015 commitment to end all long-term advisories on public First Nations water systems by 2021 was missed; substantial progress has been made (most have been lifted), but as of 2026 several still remain in effect.

The 21st century has also produced new sanitation challenges that the 19th-century framework did not anticipate. Antimicrobial resistance is partly a sanitation problem — overcrowding, weak infection control, and antibiotic contamination of waste streams all contribute. Climate change is degrading water infrastructure in some regions and producing flooding-related contamination in others. Pharmaceutical and chemical contaminants in water (microplastics, PFAS 'forever chemicals,' pharmaceutical residues) are new categories of concern. The basic insight remains: sanitation is enormous public health work, mostly invisible when it functions, catastrophic when it fails. The 21st century needs new versions of the sanitary revolution at least as much as the 19th did.

Introduction and Overview

Vaccination is the only public health intervention that has eradicated a human disease. Its history spans more than 220 years, from Edward Jenner's 1796 observation that milkmaids who had had cowpox were protected against smallpox, through to the mRNA vaccine platforms deployed against COVID-19 in 2020. The story is one of incremental scientific advance punctuated by transformative moments — and it is also a story of controversy, hesitancy, and political contestation that has shadowed every major vaccine introduction. Vaccination has saved more lives than any single medical intervention in history (by some estimates, more than 6 million lives per year currently from childhood immunization alone). It has also been resisted, doubted, and politicized in almost every era it has existed. This section traces the arc.

Edward Jenner and the founding of vaccination

The founding observation of vaccination is rooted in folk medicine. By the late 18th century, dairy farmers and milkmaids in rural England had observed for generations that exposure to cowpox — a relatively mild disease that produced lesions on cows' udders and, by transmission, on the hands of milkers — appeared to protect against smallpox. Smallpox at the time was killing roughly 400,000 people per year in Europe alone, with most cases occurring in children, and survivors were often left scarred or blind. Variolation — deliberately introducing material from a smallpox lesion into a healthy person to produce a mild case and subsequent immunity — had been practiced for centuries in China, India, and the Ottoman Empire, and had been introduced to England in 1721 by Lady Mary Wortley Montagu. Variolation worked but carried ~1-2% mortality and risk of starting new smallpox outbreaks.

Edward Jenner (1749–1823), a country physician in Gloucestershire, took the folk observation seriously. In May 1796, he scratched material from a cowpox lesion (taken from milkmaid Sarah Nelmes) into the arm of 8-year-old James Phipps. Phipps developed a mild local reaction and a brief fever. Six weeks later, Jenner deliberately exposed Phipps to material from a smallpox lesion. Phipps did not develop smallpox. Jenner repeated the experiment on additional subjects with consistent results and published his findings in 1798. He coined the term 'vaccination' from the Latin vacca (cow). Jenner's technique was rapidly adopted across Europe and the Americas during the early 19th century. King George III gave him the substantial sum of £30,000 in research support — extraordinary government recognition of medical research at the time.

The Jenner story is often told as a model of careful scientific observation translating into life-saving practice. The reality is more complicated. Jenner's experimental ethics — deliberately exposing a child to smallpox, without modern informed consent procedures, with substantial risk of death — would not be acceptable today. The technique spread despite (not because of) the medical establishment, with significant lay support and equally significant lay resistance. Compulsory vaccination acts in 19th-century Britain generated organized opposition — the Anti-Vaccination League was founded in 1853 — that anticipated the modern vaccine-hesitancy movement in many ways. The technical achievement was real and transformative; the political and social work required to implement it was difficult then as now.

Smallpox eradication: the only one

The 20th-century vaccination story culminated in the only complete eradication of a human disease ever achieved. The WHO Smallpox Eradication Programme was authorized by the World Health Assembly in 1959 and intensified in 1967 under the leadership of American epidemiologist Donald Henderson (1928–2016). At programme launch, smallpox was killing approximately 2 million people per year globally, with around 10-15 million cases annually. The eradication target seemed wildly ambitious. It worked.

The strategy combined two elements. Mass vaccination increased population immunity, particularly in high-prevalence regions. But the more innovative element was surveillance-containment or ring vaccination: when a case was identified, the response was to vaccinate every contact, every contact's contacts, and the surrounding community within a defined radius. The strategy, developed in the Nigerian and Indian portions of the campaign, was vastly more efficient than blanket mass vaccination once cases became rare. It is now the standard approach for outbreak response in many infectious diseases, including most recently the Ebola response and elements of COVID-19 contact tracing.

The last endemic case of smallpox was Ali Maow Maalin, a 23-year-old hospital cook in Somalia, on 26 October 1977. The last person to die of smallpox was Janet Parker, a British medical photographer who acquired the disease through a laboratory exposure in Birmingham in 1978. Smallpox was certified as eradicated by the WHO on 8 May 1980 — a milestone now marked annually. The total cost of the campaign was approximately US$300 million (in 1967 dollars; roughly US$2 billion in 2026 dollars). The ongoing avoided cost — in lives, in medical care, in vaccine production that no longer happens — is essentially unmeasurable but extraordinarily large.

The smallpox playbook continues to inform every contemporary eradication effort. The polio eradication campaign, launched in 1988 and ongoing, has used analogous strategies. Polio has been pushed to fewer than 30 wild cases globally in 2024 (down from ~350,000 cases in 1988), but the last reservoirs (in Afghanistan and Pakistan) are in conflict zones where vaccinators are killed and the security infrastructure for eradication is fragile. Whether polio will join smallpox as eradicated remains an open question.

The 20th-century vaccine pipeline

Between roughly 1920 and 2000, vaccines were developed for nearly every major childhood infectious disease that had been the dominant cause of childhood mortality a generation earlier. Diphtheria toxoid (1923), pertussis (1926), tetanus toxoid (1924), and combined DPT (1948) protected against the three leading causes of childhood mortality in industrialized countries. Yellow fever vaccine (1937) became the first vaccine against a virus, developed by Max Theiler (Nobel Prize 1951). The influenza vaccine, in successive forms, has been produced annually since the 1940s.

Polio vaccines were the great mid-century achievement. Jonas Salk's inactivated polio vaccine (IPV) was tested in one of the largest clinical trials ever conducted (1.8 million children, 1954) and licensed in 1955. Albert Sabin's live attenuated oral polio vaccine (OPV) was developed in parallel, tested initially in the Soviet Union, and licensed in 1961. The two vaccines have somewhat different profiles — Salk's is safer but requires injection and produces less mucosal immunity; Sabin's is cheaper, orally administered, and produces stronger mucosal immunity but in rare cases (~1 per 750,000 doses) reverts to virulence and causes vaccine-derived polio. Modern polio campaigns use both, with OPV phased out in eradication endgame strategies.

The MMR vaccine (combined measles, mumps, and rubella, introduced 1971) eliminated measles as a routine childhood illness in most high-income countries by the 1980s. Measles mortality, which had been ~6 million globally in 1970, was reduced by roughly 95% by 2015. The HPV vaccine, introduced in 2006, is driving sharp declines in cervical cancer in countries with high uptake; Australia, with the highest HPV vaccination rates globally, is on track to eliminate cervical cancer as a public health concern by 2030.

Each of these vaccines required decades of incremental scientific work and substantial public health implementation effort. None was uncontested. Pertussis, MMR, and HPV vaccines have all generated organized opposition at various points. The 1998 Wakefield paper in The Lancet, which falsely claimed an association between MMR vaccine and autism, was a watershed event for modern vaccine hesitancy; the paper was retracted in 2010, Wakefield was struck off the UK medical register, and subsequent studies of millions of children have shown no association between MMR and autism. The damage to public confidence took longer to repair than the falsification took to publish, and the consequences continue.

mRNA: a 30-year overnight success

The mRNA vaccine platform deployed against COVID-19 in late 2020 is sometimes described as a breakthrough technology developed in 2020. It is not. It is the product of three decades of largely-unrewarded basic science, primarily by Hungarian-American biochemist Katalin Karikó and her American collaborator Drew Weissman (Karikó et al., 2005), working primarily at the University of Pennsylvania from the 1990s onward.

The basic idea is to deliver messenger RNA — the molecule that codes for a specific protein — into human cells, which then use the mRNA to produce the encoded protein and trigger an immune response. The technique offered enormous theoretical advantages: vaccines could be designed within days of identifying a target pathogen (rather than the months or years required for traditional vaccines); they could be manufactured at scale using standardized processes; and they could in principle be applied to almost any infectious disease or cancer immunotherapy target. The technical obstacles were enormous: mRNA is rapidly degraded by enzymes in the body; it triggers strong inflammatory responses that can be dangerous; and getting it into cells without destruction is non-trivial. Karikó and Weissman spent the better part of two decades solving these problems, often unable to attract funding and operating on the margins of academic legitimacy.

When SARS-CoV-2 was sequenced and shared globally on 11 January 2020, two companies — Moderna and BioNTech (partnered with Pfizer) — used the Karikó-Weissman platform to design vaccine candidates within hours. Phase 1 clinical trials began within weeks. Phase 3 efficacy data was published in November 2020 (Polack et al., 2020). Emergency-use authorization for both vaccines came in December 2020. The first mass vaccinations began on 8 December 2020 (UK), 14 December 2020 (US), and shortly thereafter in Canada and elsewhere. From genome to deployment was approximately 11 months — by far the fastest vaccine development in history. By the end of 2021, roughly 10 billion vaccine doses had been administered globally.

Karikó and Weissman were awarded the 2023 Nobel Prize in Physiology or Medicine for the underlying mRNA work. Their decades of preparatory science made the speed of COVID-19 vaccine deployment possible; the speed itself reflected a unique combination of basic-science readiness, regulatory flexibility, manufacturing scale-up, and political will. mRNA platforms are now being applied to influenza (mRNA flu vaccines may largely replace traditional flu shots), RSV, HIV, malaria, and a range of cancers. The technology is genuinely transformative; the COVID-19 deployment was, in this sense, a long-prepared overnight success.

Introduction and Overview

Every generation since 1900 has had at least one defining infectious-disease event. Each has reshaped what public health does next. This section walks through the four most consequential pandemic-era events of the past century — the 1918 influenza pandemic, the HIV/AIDS pandemic, SARS in 2003, and COVID-19 — and then turns to the slow-motion crisis of antimicrobial resistance (AMR), which is unlike any of them in form but exceeds most of them in eventual scale. Each event taught the field something. Each has changed how public health is organized, what it tracks, and what it prepares for. Each also produced failures — sometimes spectacular ones — that the field is still learning from.

The 1918 influenza pandemic

The 1918 influenza pandemic, often called the 'Spanish flu' (a misnomer; the pandemic did not originate in Spain), killed an estimated 50 million people worldwide between 1918 and 1920, with some estimates ranging as high as 100 million (Johnson & Mueller, 2002). The pandemic occurred in three waves; the second wave (autumn 1918) was the most lethal. The virus — later identified as a particularly virulent H1N1 influenza A subtype — was unusual in that it killed disproportionately healthy young adults (the W-shaped mortality curve), likely through a cytokine-storm mechanism in immunologically vigorous individuals.

The pandemic occurred in a context that limited public health response: WWI was in its final year, with millions of soldiers moving between continents in conditions that facilitated spread. Public health infrastructure was rudimentary by modern standards. There were no antivirals, no vaccines (the influenza virus itself was not isolated until 1933, and the first influenza vaccines came in the 1940s), no respirators in the modern sense, and limited capacity to treat secondary bacterial pneumonia (which killed most of the dead). Mortality records for 1918 are incomplete in many countries; the demographic 'crater' the pandemic left in birth cohorts is still visible in 21st-century life-expectancy curves.

The 1918 pandemic was forgotten with extraordinary speed. By the 1930s, it was rarely discussed publicly even by those who had lived through it. The reasons are debated — the trauma of WWI may have absorbed much of the public memory; the disease was 'just flu' in a way that didn't fit later narratives of conquerable diseases. The forgetting itself shaped subsequent pandemic preparedness in a particular way: when SARS emerged in 2003 and again when H1N1 emerged in 2009, public health officials had to argue from historical analogy with an event most people had never heard of. The COVID-19 pandemic of 2020 was the event that finally restored 1918 to public memory in many countries.

HIV/AIDS: from 'GRID' to U=U

The first cases of what would become recognized as HIV/AIDS were reported by the U.S. CDC's Morbidity and Mortality Weekly Report on 5 June 1981 — five cases of Pneumocystis carinii pneumonia in previously healthy gay men in Los Angeles. Within months, similar cases were being reported across the United States and in Europe. The syndrome was briefly called 'GRID' (gay-related immune deficiency) before broader case-finding showed it affected hemophiliacs, injection drug users, blood transfusion recipients, and infants born to infected mothers. The virus now called HIV (Human Immunodeficiency Virus) was identified in 1983-1984 by groups led by Luc Montagnier (Paris) and Robert Gallo (US), in a long-running priority dispute eventually resolved by sharing credit.

The first generation of the HIV pandemic, from approximately 1981 to 1996, was characterized by extraordinarily high mortality and limited treatment. Average time from HIV infection to death without treatment was approximately 10-12 years; for those who developed AIDS-defining illnesses, life expectancy was typically 1-3 years. AZT, the first antiretroviral, was introduced in 1987 but was used as monotherapy and was associated with substantial toxicity and rapid emergence of resistance. The political and social response was disastrously slow; in the US, President Reagan did not publicly speak the word 'AIDS' until 1985, four years and tens of thousands of deaths into the pandemic.

The transformative moment came in 1996 with the introduction of highly active antiretroviral therapy (HAART) — combinations of three or more antiretroviral drugs that suppressed viral replication and prevented resistance emergence. The shift from AZT monotherapy to combination therapy was driven in substantial part by activist pressure on regulatory agencies. People with HIV who responded to HAART went from preparing to die to planning long lives. By 2008, the Swiss Federal Commission for HIV/AIDS could announce — and by 2016, this was global consensus — that U=U: a person with HIV on effective treatment, with sustained undetectable viral load, does not transmit HIV sexually. HIV is now, in countries with adequate treatment access, a chronic manageable condition with near-normal life expectancy.

The HIV pandemic transformed the relationship between research, regulators, and affected communities. ACT UP (AIDS Coalition to Unleash Power, founded 1987 by playwright Larry Kramer and others) used direct-action protest, public confrontation of researchers, and policy advocacy to force changes in how clinical trials were conducted, how drugs were approved, and how treatment access was structured. The phrase 'Nothing about us without us,' borrowed from disability rights and now standard in patient-oriented research, traces in part to ACT UP. The contemporary structure of community-based participatory research, especially in HIV but increasingly across many fields, owes its character to this period.

SARS, H1N1, Ebola — the rehearsal years

Between 2003 and 2015, three substantial outbreaks tested global pandemic preparedness and, in different ways, prefigured COVID-19. SARS (Severe Acute Respiratory Syndrome, caused by SARS-CoV-1) emerged in southern China in late 2002 and was identified in early 2003. International spread occurred rapidly through air travel, particularly to Hong Kong, Toronto, Singapore, and elsewhere. Toronto's outbreak was particularly severe — 44 deaths in two waves, with substantial healthcare-worker infections and the partial shutdown of the city's hospital system. SARS killed approximately 800 people globally and infected around 8,000 before being contained through aggressive case identification, isolation, and contact tracing. The outbreak ended in mid-2003. SARS-CoV-1 has not been detected in humans since.

SARS's institutional consequences in Canada were substantial. The 2003 Naylor Report reviewed Canada's response and identified profound gaps: case definitions were inconsistent, federal coordination was inadequate, communication with provinces was ad hoc, surveillance systems were not interoperable. The Public Health Agency of Canada (PHAC) was created in 2004 as a direct response. The lessons of SARS were not fully implemented before COVID-19 hit — a recurring pattern of post-outbreak commitments fading with time — but the institutional groundwork mattered enormously.

H1N1 (the 2009 'swine flu' pandemic) was a moderate-severity influenza pandemic that tested pandemic preparedness plans developed after SARS. The novel H1N1 virus emerged in Mexico in early 2009 and spread globally within months. Mortality was lower than initially feared, but the pandemic exposed the fragility of global vaccine supply chains and the difficulty of producing pandemic vaccines on the timescale required. Most countries' H1N1 vaccines arrived after the peak of disease activity. The experience reshaped pandemic planning toward stockpiling, faster regulatory pathways, and the rapid vaccine technologies (including mRNA preparation) that would prove decisive in 2020.

Ebola outbreaks have occurred periodically since the virus was first identified in 1976. The 2014-2016 West African Ebola outbreak — centered in Guinea, Liberia, and Sierra Leone — was the largest in history, with over 28,000 cases and approximately 11,000 deaths. The outbreak revealed massive gaps in global health emergency response: the WHO declared the outbreak a Public Health Emergency of International Concern only in August 2014, months after substantial spread; international assistance was slow and uneven; the affected countries' health systems collapsed under the strain. The post-Ebola reforms (including the WHO's Health Emergencies Programme, established 2016) attempted to address these gaps. They were not fully implemented when COVID-19 emerged.

COVID-19 and the slow pandemic of AMR

The COVID-19 pandemic beginning in late 2019 is the largest single public health event of the past century outside wartime. As of late 2025, official global death counts were approximately 7 million; excess-mortality analyses suggest the true toll is 20-25 million. The economic, social, and educational disruption is impossible to summarize briefly. The scientific response was extraordinary: SARS-CoV-2 was sequenced and the sequence shared globally within days of identification; vaccines were developed and deployed within 11 months; therapeutics including monoclonal antibodies, antivirals (Paxlovid), and improved supportive care emerged through 2020-2022. The public health response was variable: some jurisdictions (notably parts of East Asia, New Zealand, and Australia early in the pandemic) achieved remarkable containment; others, including much of Europe and North America, experienced sustained high mortality.

COVID-19's lessons are still being processed. Some are clear: surveillance systems built for influenza did not translate well to SARS-CoV-2; case-counting was inconsistent across jurisdictions in ways that complicated international comparison; the importance of indoor air quality (long underappreciated) was suddenly visible; and the population-level effects of school closures, social isolation, and labor-market disruption were larger than initially recognized. Other lessons are contested: the relative effectiveness of various non-pharmaceutical interventions, the optimal timing of opening and closing, and the appropriate role of vaccine mandates remain matters of substantive disagreement. Public health communication during COVID-19 was both essential and often poor; rebuilding trust is an active project.

While COVID-19 occupied global attention, antimicrobial resistance (AMR) continued to grow as a slow-motion crisis. Modeling estimates suggest AMR was associated with approximately 4.95 million deaths globally in 2019 — more than HIV/AIDS at its peak (Murray et al., 2022). The AMR threat is structural: antibiotics, like all infectious-disease therapeutics, exert selection pressure that favors resistant organisms; resistance has been observed for essentially every antibiotic ever introduced; new antibiotic development is slow and economically unattractive to pharmaceutical companies. The result is a creeping reduction in clinical effectiveness of antibiotics. Some pathogens (carbapenem-resistant Enterobacteriaceae, extensively drug-resistant tuberculosis) are now essentially untreatable in some cases.

Unlike COVID-19, AMR has no event horizon. It kills more people per year than COVID-19 did in most years, but the deaths are dispersed across hospitals and care homes, individually attributed to other diagnoses (sepsis from an untreatable infection), and not connected to a salient cause. Political action requires a politically legible event — and slow pandemics are illegible to most political systems. This is a generalizable lesson: the public health problems most likely to be addressed are not necessarily the largest, but the most visible.

Bringing It All Together

This lesson has walked you through the full arc of the topic across all four sections. As you complete this final assessment, draw on each section to consolidate what you have learned and to prepare for the lessons that build on it.

The list below distills the core ideas the rest of the course will keep coming back to. Read them as a checklist: if any feel unfamiliar, jump back into the relevant section before you take the assessment, since later lessons will assume each of them as common ground.

Data Spotlight

Forward Link

HSCI 230 will teach the formal study designs (outbreak investigations, case-control, cohort) that public health uses to characterize infectious and chronic disease. HSCI 341 will cover surveillance methodology in depth, including the case definitions, system evaluation, and outbreak investigation work that PHAC and BCCDC actually perform. The historical context in this lesson lets you read those methodological treatments as the natural descendants of Snow, Pasteur, Koch, and the smallpox eradicators.

Final Reflection

Comprehensive Knowledge Check

This 15-question assessment covers all four sections of Lesson 3. Aim for at least 12 of 15 correct. You may retry until you reach mastery.